Introduction: Plasma levels of Hs-CRP may be useful to select subjects at high risk of cardiovascular events. This inflammatory marker also helps identify patients most likely to respond to statins. Aim: A prospective clinical study was designed to investigate in a population of stable IHD patients treated with Atorvastatin: a) the regression of CRP levels and other soluble inflammatory" markers; b) the correlations between levels of Carotid Intima Media Thickness (C-IMT) and a series of soluble markers at different times; c) the influence of Hs-CRP levels on C-IMT regression; d) the utility of C-IMT as an additional marker to identify patients likely to respond to statins. Materials and Methods: MIAMI is an open, multicenter, independent study. In 100 patients with previous MI (> two months), in stable clinical conditions, with normal cholesterol and blood glucose, receiving atorvastatin (20 mg/daily) for 24 months, the following variables were measured at 0, 12 and 24 month: VCAM, ICAM, E-selectins, IL-6, -8, -10, -18, TNF-alpha, hs-CRP, MMP-9, TF, TFPI, Fg, TC, HDL, LDL, TG, urinary isoprostanes. C-IMT was measured blindly by computerised determination of images recorded in three examinations. The study started in January 2003 and is scheduled to end in December 2005. Topic Preferences: 1) New Markers for Cardiovascular Risk (18.) 2) Inflammation and Atherosclerosis (21.) 3) Pleiotropic effects of Lipid Lowering Drugs (41.)

The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) / M. Arquati, B. Porta, M. Camera, D. Baldassarre, E. Tremoli, M. Cortellaro on behalf of the MIAMI study group. ((Intervento presentato al 15. convegno international symposium of DRUG AFFECTING LIPID METABOLISM tenutosi a Venezia nel 2004.

The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study)

B. Porta
Secondo
;
M. Camera;D. Baldassarre;E. Tremoli
Penultimo
;
M. Cortellaro on behalf of the MIAMI study group
2004

Abstract

Introduction: Plasma levels of Hs-CRP may be useful to select subjects at high risk of cardiovascular events. This inflammatory marker also helps identify patients most likely to respond to statins. Aim: A prospective clinical study was designed to investigate in a population of stable IHD patients treated with Atorvastatin: a) the regression of CRP levels and other soluble inflammatory" markers; b) the correlations between levels of Carotid Intima Media Thickness (C-IMT) and a series of soluble markers at different times; c) the influence of Hs-CRP levels on C-IMT regression; d) the utility of C-IMT as an additional marker to identify patients likely to respond to statins. Materials and Methods: MIAMI is an open, multicenter, independent study. In 100 patients with previous MI (> two months), in stable clinical conditions, with normal cholesterol and blood glucose, receiving atorvastatin (20 mg/daily) for 24 months, the following variables were measured at 0, 12 and 24 month: VCAM, ICAM, E-selectins, IL-6, -8, -10, -18, TNF-alpha, hs-CRP, MMP-9, TF, TFPI, Fg, TC, HDL, LDL, TG, urinary isoprostanes. C-IMT was measured blindly by computerised determination of images recorded in three examinations. The study started in January 2003 and is scheduled to end in December 2005. Topic Preferences: 1) New Markers for Cardiovascular Risk (18.) 2) Inflammation and Atherosclerosis (21.) 3) Pleiotropic effects of Lipid Lowering Drugs (41.)
2004
Settore BIO/14 - Farmacologia
The regression between multiple inflammatory markers and C-IMT in normocholesterolemic stable IHD. The effect of moderate dose of atorvastatina (MIAMI study) / M. Arquati, B. Porta, M. Camera, D. Baldassarre, E. Tremoli, M. Cortellaro on behalf of the MIAMI study group. ((Intervento presentato al 15. convegno international symposium of DRUG AFFECTING LIPID METABOLISM tenutosi a Venezia nel 2004.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/211916
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact